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We describe the isolation and detailed structural characterization
of stable toxic oligomers of α-synuclein that have accumulated dur-
ing the process of amyloid formation. Our approach has allowed
us to identify distinct subgroups of oligomers and to probe their
molecular architectures by using cryoEM image reconstruction
techniques. Although the oligomers exist in a range of sizes, with
different extents and nature of β-sheet content and exposed hy-
drophobicity, they all possess a hollow cylindrical architecturewith
similarities to some types of amyloid ﬁbril, suggesting that the
accumulation of at least some forms of amyloid oligomers is likely
to be a consequence of very slow rates of rearrangement of their
β-sheet structures. Our ﬁndings reveal the inherent multiplicity
of the process of protein misfolding and the key role the β-sheet
geometry acquired in the early stages of the self-assembly process
plays in dictating the kinetic stability and the pathological nature
of individual oligomeric species.
Protein misfolding j Amyloid aggregation j toxic oligomer j cryoelec-
tron microscopy j neurodegeneration
Medical disorders associated with amyloid formation, which
include Alzheimer’s disease, Parkinson’s disease (PD) and di-
abetes mellitus type 2, share a common feature, namely the
presence of deposits of abnormally aggregated proteins within the
body (1, 2). Whilst the specific protein molecule that is found to
be the major component of such deposits varies from one disease
to another, the formation of the pathological aggregates appears
to occur by a common process of misfolding and self-assembly of
a normally soluble polypeptide chain into a series of oligomeric
intermediates, and ultimately into insoluble amyloid fibrils that
accumulate within specific organs and tissues.
It has been found that amyloid fibrils can be formed in vitro
from a very wide range of proteins in addition to those involved
in disease and, like fibrils extracted from patients suffering from
amyloid-related diseases, they possess a common core architec-
ture, the “cross-β” structure, in which β-strands align perpendic-
ular to the fibril axis and thus generate arrays of β-sheets that
are oriented parallel to the fibril axis (3). Despite their highly
insoluble but non-crystalline nature, which has hampered their
detailed structural determination by traditional methods, several
structural descriptions of fibrillar assemblies have recently been
reported, some at atomic resolution (4, 5), greatly enhancing
our understanding of the different levels of structural complexity
inherent in the amyloid cross-β structure. The universality of
this architecture has been attributed to the nature of the intra
and intermolecular interactions within the β-sheets, which are
dominated by hydrogen bonds between the main-chain atoms
that are common to all polypeptide chains (6). Information from
a variety of techniques suggests that the fibrils typically result
from the assembly of a number of protofilaments, each made up
of a double layer of β-sheets, which wind around one another
to form twisted structures. In most cases there is evidence for
water-filled interfaces between protofilaments (4, 5, 7-10), which
have analogies with such interfaces observed in structures of small
peptides that assemble into amyloid-like microcrystals (11).
Significant advances have therefore been made towards un-
derstanding the structures of fibrillar aggregates, but little de-
tailed structural information (12) is currently available for the
oligomeric species that are frequently observed to accumulate as
intermediates in the process of fibril formation, despite increasing
evidence that such species can be highly cytotoxic (1, 13, 14)
and may be key players not only in the initiation of disease
but also in its spreading through cell-to-cell transmission (15).
Structural characterization of oligomers is, however, particularly
challenging because of their often transient nature and, even
more importantly, because of the variability of these species
both in terms of size (from dimers to high order multimers) and
structure (in principle, from essentially random coil to a similar
degree of β-sheet content to that observed in the fibrillar species).
It is therefore of the utmost importance that this intrinsic het-
erogeneity of oligomeric samples is appropriately controlled and
understood if meaningful structural models are to be obtained
and related to their toxicity.
Signiﬁcance
Certain oligomeric forms generated during the assembly of
speciﬁc proteins into ordered ﬁbrillar aggregates are likely
key players in the initiation and spreading of neurodegen-
erative diseases. We have puriﬁed stable toxic oligomeric
species of α-synuclein and deﬁned and minimized their degree
of heterogeneity, which has allowed us to identify distinct
subgroups of oligomers and determine their structural prop-
erties and three-dimensional molecular architectures. All the
oligomeric subgroups possess cylindrical architectures with
marked similarities to amyloid ﬁbrils, suggesting that these
types of oligomers are kinetically trapped during protein self-
assembly. The relative stabilities and inherent pathological
roles of different amyloid oligomers are likely to result from
the multiplicity of pathways of the misfolding process and the
remarkably slow rates of structural conversions.
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Fig. 1. Determination of the size distribution of the puriﬁed αS oligomeric
samples.A) HPLC-SEC analysis of the composition of the oligmeric samples;
the oligomeric fraction eluted at 14.5 ml and the monomeric fraction at 22
ml. The elution volumes for each protein standard used for the calibration
are also shown at the top of the ﬁgure (see also Supplemental Information).
The fractions corresponding to the oligomeric peak were collected and sepa-
rated in three groups: large oligomer HPLC fraction (area depicted in blue in
the zoomed-in image of the oligomeric peak), medium size oligomer HPLC
fraction (green area), and small oligomer HPLC fraction (orange area). The
three oligomeric solutions were then concentrated and re-injected into the
HPLC-SEC column at the same mass concentration for their analysis, bottom
panel. B) Native PAGE gel showing the different mobility of ﬁbrillar (F),
oligomeric (O), and monomeric (M) αS in comparison with protein markers
(ﬁrst lane). C) Sedimentation velocity analysis of the αS oligomeric sample.
The solid line represents the size distribution of sedimenting species obtained
by c(s) analysis (see Experimental Procedures). In the insert, the experimental
data (symbols), their ﬁt to the model (solid lines) and their residuals (below)
are shown. For clarity, only one in every nine scans is represented. D)
Representative DLS-derived size distribution of 45 μMmonomeric (red bars),
5 µM oligomeric (blue bars) and 3 µM ﬁbrillar (black bars) αS solutions.
Despite these challenges, intense research has elucidated a
number of common features between amyloid oligomers formed
by different systems (16). In the particular case of α-synuclein
(αS), whose deposition is the hallmark of PD, a number of
enriched samples in stable oligomeric species has been reported
(17-22), which appear to have some common general features,
but significant differences in structures, relationships to fibril
formation, and proposed mechanisms of toxicity.
We report here the detailed characterization of an ensemble
of toxic oligomeric species formed by αS, whose existence and
relationship to amyloid fibril formation has previously been de-
termined by single-molecule studies (23). This characterization
has been achieved by the application of a set of complemen-
tary biophysical techniques, including a variety of spectroscopic
techniques along with analytical ultracentrifugation (AU), atomic
force microscopy (AFM), and electron microscopy (EM), to pro-
vide a detailed understanding of the structural properties of this
type of complex aggregate. The results of this study provide the
basis for a more complete understanding of the nature of the self-
assembly of polypeptides into β-sheet rich amyloid aggregates,
providing a unifying view of the protein misfolding process, and
potentially contributing to efforts to identify specific targets for
drug discovery.
Results
Preparation and preliminary characterization of the ensemble of
αS oligomers
The inherently transient nature of oligomeric intermediates
generated during the formation of amyloid fibrils normally results
in their presence as a very low fraction of all the protein species
in the sample at any time of the reaction. Alternative procedures
have, therefore, been used to try to isolate these types of species
in order to characterize them and obtain a better understanding
of their structural properties. In the present study we have made
used of lyophilization (an approach widely used previously to
generate αS oligomeric samples (17, 21, 22, 24-28)) to increase
significantly the formation of αS oligomeric species, an effect
that can be attributed to a combination of factors including a
significant increase in the area of the solvent/air interface (29) and
a decrease in the intermolecular distances during the vitrification
process. The final composition of the purified oligomeric samples
used in this study (see Figure S1 for the analysis of the kinetic
stability of the oligomeric samples) was assessed by HPLC-SEC
(Figure 1A) and found to consist of ca. 90 % of oligomers
with apparent molecular weights of ca. 650-1100 kDa (similar
values, ca. 800-1200 kDa, were obtained from native-PAGE gel
electrophoresis; Figure 1B) and 10 % of monomers, a feature
that is likely to be the result of dissociation of some of the more
labile oligomers. A similar level of monomeric protein was also
observed in samples subjected to AU (see Figure 3A-B), and has
been accounted for when defining the spectroscopic properties
of the oligomeric species. Initial attempts to separate oligomers
of different sizes by HPLC-SEC (Figure 1A) were unsuccsessful,
suggesting that the oligomeric sample is able to re-equilibrate
at least to some extent during the time needed for their re-
analysis; we were able, however, to tune the size distribution of
the oligomers by adding different concentrations of urea to the
sample, as discussed below.
Accurate determination of the size distribution of the αS
oligomers
Although native PAGE and standard SEC techniques were
useful to give initial assessments of the sizes and level of het-
erogeneity of the various protein samples, a more sophisticated
method of analysis was needed to establish accurately the distri-
bution of sizes present with such complex mixtures of species.
We therefore carried out AU measurements of sedimentation
velocities and obtained very similar velocity profiles for different
batches of freshly prepared purified oligomeric samples (see
Figure 1C and Figure 3A for a comparison), indicating the high
reproducibility of our preparation protocol. The data were then
analyzed by two complementary approaches (30, 31) (see Exper-
imental Procedures), which yielded very similar distributions of
sedimentation coefficients for the ensemble of particles in the
sample.
The sedimentation velocity profiles showed a significant poly-
dispersity in size for the oligomeric species, although two broad
peaks are clearly distinguishable, with S20,w values of 7.3 - 13.3 ± 1
S (peak maximum at 10.3 S) and 12.2 - 18.2 ± 1 S (peak maximum
at 15.2 S) and a relative abundance in mass concentration in
the sample of 30 ± 3 % and 50 ± 3 %, respectively (note that
the absorbance reflects the relative mass concentration of the
particles), and a very minor additional group of species (ca. 10
% in mass) with larger S20,w values, up to 28 S (Figure 1C). The
S20,w values of these species together with the corresponding best-
fit values of the frictional ratio, f/f0 (a parameter related to the
asymmetry of the protein molecules), were then correlated with
the values estimated from the cryoEM-derived 3D structures (see
sections below) using HYDROMIC (32). Using this approach,
the association state (the average number of protein molecules in
an oligomer) for the 10S oligomer subgroup was determined to
be 11 - 25 (an average of 18) (f/f0 of 1.40 ± 0.10) and for the 15S
oligomer subgroup to be 19 - 39 (an average of 29) (f/f0 of 1.32 ±
0.10), corresponding to molecular weights of 160 - 360 kDa (an
average of 260 kDa) and 280 - 560 kDa (an average of 420 kDa),
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
2 www.pnas.org --- --- Footline Author
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
Submission PDF
Fig. 2. Morphological and structural characterization
of the oligomeric αS species. Examples of AFM images
of monomeric (A), oligomeric (B) and ﬁbrillar (C) αS
species. The color-coding represents the surface to-
pography (height) and the scale bar is shown at the
bottom of each image. D) Representative TEM image
of the αS oligomeric samples. E) Far-UV CD, F) FT-IR,
G) ThT ﬂuorescence, and H) ANS ﬂuorescence spectra
of monomeric (red line), oligomeric (blue line) and
ﬁbrillar αS solutions (black line) at the same mass con-
centration. The spectrum of the buffer is also shown
as thin dashed black lines. In panel F), the position of
the aborbance band characteristic of anti-parallel β-
sheet structure present in the oligomeric species but
absent in the ﬁbrillar forms is highlighted in blue.
Fig. 3. Detailed characterization of the individual structural properties of the different sized subgroups of oligomers. A) AU sedimentation velocity
experiments of the oligomeric samples in the presence of different urea concentrations. A zoomed-in view of the size proﬁle of the oligomeric fraction is
shown in the insert. B) Fractions of monomeric (in red) and oligomeric species (in blue) in the oligomeric samples, as a function of urea concentration, estimated
by AU. The fraction of the two main oligomeric size subgroups is also represented: the 15S oligomer subgroup in green and the 10S oligomer subgroup in
orange. The average sedimentation coefﬁcient of the oligomeric fraction at different urea concentrations is also shown (black circles). The error bars represent
experimental errors. Correlation of the secondary structure content (C) and the degree of hydrophobic surface area exposed to the solvent (represented as
the wavelength of the maximum ﬂuorescence emission of ANS) (D) with the size of the oligomers (blue symbols represent the experimental data and the
line, the correlation function; see Supplemental Experimental procedures). Estimates of the β-sheet content by FT-IR of two independent oligomeric samples,
corresponding to one prepared with freshly puriﬁed protein and another prepared with reused ﬂow-thorugh solutions (orange symbols; see Figure S4), overlie
with the overall trend obtained by far-UV CD analysis (blue symbols). The orange and green arrows indicate the estimated averaged β-sheet content for the
10S and 15S oligomeric subgroup, respectively.
respectively; the additional larger species present at low levels
correspond to particles containing up to 90 protein molecules
(molecular weights up to ∼ 1300 kDa) and were included in the
15S subgroup for their further structural characterization. The
calculated values of the frictional ratios for the two subgroups are
consistent with hydrated globular/spherical particles, rather than
elongated species.
Definition of the secondary structure content and hydropho-
bic character of the oligomeric αS species
We next set out to characterize the overall morphologies of
the oligomeric species in the samples by means of AFM tech-
niques (Figure 2A-C). While the fibrillar species appear as uni-
form thread-like structures of 0.05-3.0 µm in length and 10-35 nm
in height (the large variation in heights is attributable to differing
degrees of self-association of the fibrils under these conditions),
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Fig. 4. 3D-reconstructions of the twomain size subgroups of oligomers of puriﬁed oligomeric samples. A) Example of cryoEM image of an oligomeric sample.
Representatives of the two main particle subgroups are highlighted: with arrows, for the 15S oligomeric species, and arrowheads, for the 10S oligomers. B)
Typical side view (top) and end-on view (bottom) of the small oligomeric subgroup (corresponding to the 10S oligomer subgroup) according to cryoEM. C)
The same views for the large structural group (corresponding to the 15S oligomer subgroup). D) Two orthogonal views, side (left) and end-on (right), of the
3D reconstruction of the average structure for the 10S oligomer subgroup E) The same views for the 3D reconstruction of the structure representing the 15S
oligomer subgroup.
Fig. 5. Comparison of the puriﬁed αS oligomers
with toxic oligomers previously found during αS ﬁbril
formation. A) The single-molecule FRET efﬁciency dis-
tribution of a puriﬁed αS oligomeric sample (shown in
grey bars) compared to the FRET distributions of the
two main oligomeric species (type A and type B) pre-
viously found during αS ﬁbril formation. B) Proteinase
K degradation curves of the different protein species:
monomers in red, oligomers in blue, and ﬁbrils in
black. The data represented correspond to the aver-
age and standard error of 3 different experiments.
The degradation proﬁle of type B oligomers is shown
by green circles. C) Time-resolved cytoplasmatic ROS
production (HEt: dihydroethidium) in rat midbrain
neuronal cultures after exposure to the different αS
species: monomers in red, oligomers in blue, and
ﬁbrils in black. D) Dose response effect of monomers
(M), oligomers (O) and ﬁbrils (F) on the rate of cy-
toplasmatic ROS production. The basal rate of ROS
production was taken as 100%. ***, p<0.0001. E)
Calcein release from LUVs of different POPS:POPC ra-
tios after being incubated with monomeric (red bars),
oligomeric (blue bars) and ﬁbrillar (black bars) αS, at
two different protein:lipid ratios (1:10 and 1:100). The
pore-forming peptide, mellitin, was used as positive
control (green bars). The signal obtained when the
detergent Triton X-100 was added to the vesicles was
taken as 100%. Data points are averaged triplicates
and the error bars represent the standard deviations.
*, p<0.5: **, p<0.01: ***, p<0.001: ****, p<0.0001: ns,
not signiﬁcant.
the purified oligomeric species appear to be approximately spher-
ical in the AFM images (in agreement with TEM images, Figure
2D), with heights ranging between 3 and 16 nm (Figure S2), in
agreement with a range of previous observations of oligomeric
forms of αS and (33). The dimensions of the oligomeric species
derived from the AFM data are also broadly consistent with
the solution-derived size parameters obtained by dynamic light
scattering (DLS) (Figure 1D). Interestingly, all the oligomeric
species, regardless of their size, appear to have similar spherical-
like morphologies in the AFM and TEM images.
In order to gain insight into the structural features of the
oligomers, we assessed their secondary structure content and
hydrophobicity and compared these properties to those of the
monomeric and fibrillar states. Both far-UV CD (Figure 2E)
and Fourier transform infrared (FT-IR) spectroscopy (Figure 2F)
reveal that the secondary structure content of the oligomers is
intermediate between that of the monomeric and the fibrillar
species. Deconvolution of the FT-IRdata in particular (see Figure
S3) indicates that on average the oligomers contain ca. 35 ± 5 %
of β-sheet structure, compared to none in the soluble monomers
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and ca. 65 ± 10% in the fibrils (see Figure S3); the latter estimate
is in good agreement with previous studies of the β-sheet core
of the αS fibrils (34). Furthermore, the β-sheet structure of the
oligomers appears to be able to interact with Thioflavin T (ThT)
molecules much less effectively than does that of the fibrils, as the
oligomers display ca. 10 times less ThT fluorescence intensity at
the maximum wavelength of emission as compared to the fibrils
at equivalent mass concentrations (Figure 2G).
More detailed analyis of the FT-IR data suggests that the
fibrillar conformation of αS is largely composed of parallel β-
sheet structure (shown by the presence of a band at 1620-30 cm−1
and the absence of an absorption band at ca. 1695 cm−1), but that
the β-sheet structure in the oligomeric species is predominantly
anti-parallel (as indicated by a band at ca. 1620-30 cm−1 as well
as a prominent shoulder at ca. 1695 cm−1, approx. 5-fold weaker
than the band at 1620-30 cm−1) (35) (Figure 2F and Figure S3).
Interestingly, the detection of a difference in the organization of
the β-sheet structure from a dominance of parallel β-sheet struc-
ture in the fibrillar form to that of anti-parallel β-sheet structure
in oligomeric species has been reported previously for αS (17) and
for several other amyloidogenic peptides and proteins such as the
Aβ-peptide (35), lysozyme (36), a prion-related peptide (37) and
β2-microglobulin (38).
Finally, we assessed the extent of hydrophobic surface area
exposed to the solvent in each αS species using the most widely
used solvent-sensitive dye, 1-anilinonaphtalene-8-sulfonic acid
(ANS). While the ANS fluorescence spectrum of the monomeric
protein shows identical properties to that of the fluorophore
in buffer alone (emission maximum at 526.3 ± 0.6 nm in both
cases), the increase in its quantum yield (a three to four-fold
enhancement of the fluorescence intensity with respect to the
free ANS), with a concomitant blue-shifted emission maximum
in the presence of both oligomeric and fibrillar species (emission
maximum at 492 ± 1 and 494 ± 2, respectively; Figure 2H),
indicates a greater extent of solvent exposed hydrophobic surface
per molecule of αS in the aggregated forms of the protein, being
slightly greater in the oligomeric than in the fibrillar state.
Analysis of the structural differences between the major
subgroups of αS oligomers
We have established above that the samples of purified
oligomers contain a distribution of particle sizes, but that two
distinct major size subgroups of oligomers can be differentiated
in the AU analysis: a subgroup of small oligomers, referred as the
10S oligomer subgroup, and a subgroup of larger oligomers, re-
ferred as the 15S oligomer subgroup. In addition, further experi-
ments have revealed that the relative proportion of each subgroup
of oligomers, and therefore the overall average sedimentation
coefficient of the sample, changes upon addition of chemical de-
naturants such as urea (Figure 3A).As the urea concentrationwas
increased from 0 to 3M, a large shift occurred in the average value
of the sedimentation coefficient for the oligomeric species, from
ca. 14 S to ca. 10 S; this change can be attributed to the increasing
disappearance of the 15S subgroup of oligomers, concomitant
with an increase in the fraction of monomeric protein (Figure
3B). At urea concentrations higher than 3.5 M, the oligomeric
distribution is essentially composed of only the 10S subgroup of
oligomers. Importantly, we were unable to detect oligomers with
S20,w values below ca. 7 S, even with increasing concentrations of
urea. This observation indicates that the smaller (10S) oligomers
are highly stable and remain within a rather well-defined and spe-
cific size range, and suggests that when disaggregation occurs, for
example bymonomer detachment, oligomers below a specific size
limit (corresponding to ca. 200 kDa, i.e. to ca. 14 αS molecules)
are no longer stable and rapidly disassemble into monomers.
By combining the analysis of the effects of low concentrations
of urea (up to 1.5 M; see Figure S5 for the analysis at higher
urea concentrations) on oligomeric samples prepared with both
freshly purified monomeric protein (Figure 3A-B) and the flow-
through solutions of previous oligomer purification processes
(a procedure that yields a higher fraction of larger oligomeric
species in the sample than the oligomeric samples prepared with
freshly purified protein in a reproducible manner; see Figure S4),
we were able to perform a detailed analysis of the major overall
structural features of the oligomers as a function of their size.
We found a strong correlation between the size of the oligomers
and both the β-sheet content (Figure 3C) and the surface hy-
drophobicity (Figure 3D): the smaller the oligomers, the lower
the β-sheet content and the surface-exposed hydrophobicity. As
discussed above, however, there appear to be well-defined limits
on the size of stable oligomers and therefore on their β-sheet
content and extent of hydrophobic surface area exposed to the
solvent.
Further analysis of the data for the two types of oligomer
subgroups indicates that the 15S oligomers have an average β-
sheet content per molecule of ca. 39 % (ranging from ca. 34 to 45
± 3% according to theAU-derived size distribution: 12.2 – 18.2 S)
and the highest level of exposed hydrophobic surface area of any
αS species (including the fibrils), while the smaller 10S oligomers
have an average β-sheet content of ca. 30 % (ranging from ca.
25 to 35 ± 3 % according to the AU-derived size distribution:
7.3 – 13.3 S) and an exposed hydrophobic surface area that is
smaller than both the larger oligomers and the fibrils (Figure
3C-D). Using the correlation described above between oligomer
size and β-sheet content, we predict that the β-sheet content of
the largest oligomers detected by AU (28 S) to be ca. 65 %.
This value is the same as that measured by FT-IR for the αS
fibrils but, as we discuss in more detail below, the FT-IR spectra
indicate that the β-sheet geometry is different, the oligomers but
not the fibrils having a significant content of anti-parallel strands,
and the oligomers having, on average, a higher level of exposed
hydrophobic surface relative to the fibrils. Indeed, the significant
predicted differences in surface hydrophobicity between the 28 S
oligomers and that found for the fibrils, further indicate that the
β-sheet arrangement in these two types of aggregated species is
different.
3D structural analysis of the two major subgroups of αS
oligomers
At a fundamental level, the rapid elongation rate of small
fibrils in the presence of monomer hampers the study of the
intermediate transient oligomeric species generated during the
formation of fibrils. The ability to produce and isolate trapped
oligomeric forms, such as those described here, opens up the
possibility of gaining insights into the nature and structure of
these species. In order to obtain more detailed information con-
cerning the structures of the αS oligomeric species, the samples
were analysed by electron microscopy using both negative stain
techniques in TEM(Figure S6) and direct visualisation of vitrified
unstained samples in cryoEM (Figure 4A). In both cases the
analyses revealed a small number of very large aggregates, which
were not examined further in this study, and a large number of
smaller species that were found in two main orientations (Figure
4A and S6A), one representing a ‘doughnut’ shape, similar to
that described in a number of previous reports of TEM-images
of amyloid oligomers (33, 39), while the other orientation has
a ‘cylinder-like’ appearance, also described in previous TEM
studies (33). Interestingly, both types of images, which appear
to correspond to the two main orthogonal orientations of the
oligomers, could be observed regardless of the apparent size of
the oligomeric species (Figure 4B,C and S6B).
To investigate these structures further, 7,776 and 17,242 par-
ticle images from the unstained (cryoEM) and stained samples,
respectively, were selected, processed and classified as described
in the Experimental Procedures section (see also Figure S6B-
D). In order to understand their significance we separated the
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particle images in two size subgroups, which would correspond to
the 10S and 15S species previously identified in the AU analysis
of the samples. The classification procedure showed clearly the
two main types of particle image discussed above (Figure 4B,C
and S6C). We carried out independent 3D reconstructions for
each subgroup (Figure 4D,E and S6E). The results revealed a
similar structure for both types of oligomer subgroups, albeit of
their different size: a cylinder-like structure with a region of low
electron density running through the cylinder, giving the appear-
ance of a hollow core. Both structures showed irregularities in the
cylindrical shape that are likely to reflect variations in the number
and length of the β-strands within the different oligomer particles.
The reconstruction of the 10S oligomer subgroup, which rep-
resents about 60 % of the particles analyzed, reveals a structure
that is ca. 120 Å in length and ca. 90 Å in diameter, with an
apparent central cavity of ca. 25 Å in diameter. That of the 15S
oligomer subgroup, representing about 40 % of the particles
analyzed, has a length of ca. 140 Å and a diameter of ca. 100 Å,
again with a cavity of ca. 25 Å in diameter. It is interesting that the
ratio of the length to the width of both types of oligomer is very
similar (1.33 and 1.40), as are the dimensions of the central cavity,
and that very few more elongated structures were observed.
Comparison with αS oligomers observed in single molecule
experiments
We have recently described studies of the aggregation of
αS using single-molecule fluorescence techniques that revealed
the presence of two distinct forms of oligomeric species during
fibril formation that differed in their fluorescence behaviour,
kinetics of formation, degree of compactness and susceptibility
to degradation by proteases; we denoted these forms type A and
type B, respectively (23). The rate of conversion between the two
forms was found to be very slow, of the order of tens of hours at 37
°C, and studies using rat primary midbrain neuronal cells showed
that the oligomers formed initially during αS aggregation (type
A oligomers) were essentially benign whilst those formed after
the conversion process (type B oligomers) were able to induce
a significant and aberrant production of reactive oxygen species
(ROS).
In order to assess whether or not the purified oligomers
characterized here could be similar to one or other of these two
forms of oligomers previously found to form during αS aggrega-
tion (23), we first compared their fluorescent properties, partic-
ularly the distribution of fluorescence resonance energy transfer
(FRET) efficiencies obtained by single-molecule fluorescence of
the purified oligomeric samples described here with the FRET
distributions of the type A and type B oligomers (see Supple-
mental Experimental Procedures and Figure S7) . The single-
molecule FRETdistributions of the dual labeled (AlexaFluor-488
as FRET donor and AlexaFluor-647 as FRET acceptor) purified
oligomeric samples (as well as their apparent size distributions;
see Figure S8) were found to overlap completely with the equiva-
lent data obtained in our previous study for the type B oligomers
generated during αS fibril formation (Figure 5A). In addition,
both types of oligomers showed identical degrees of resistance
against proteinase-K (PK) degradation (Figure 5B), which were
intermediate between that exhibited by the monomeric protein
(that is readily degradable because of its intrinsically disordered
nature), and the fibrillar form of the protein (that is highly
resistant to degradation because of its very stable cross-β-sheet
structure (34)). Taken together, these findings indicate that the
structures of the purified oligomers studied in this work are
closely similar to the toxic typeB oligomers observed in the single-
molecule experiments to be populated during the aggregation
reaction. In addition, the similarities between oligomeric forms
generated using the protocol described here and those detected
under conditions in which fibrils can form (17, 20-22, 24, 26, 27)
indicates that oligomeric structures of similar compactness and
overall quaternary structure are formed under a variety of condi-
tions, suggesting a common mechanism for the self-assembly of
polypeptide chains into β-sheet rich aggregates.
Toxicity of the αS oligomers
Given the high structural similarities between the purified
oligomers characterized here and the type B oligomers generated
during the aggregation of αS, we assessed whether or not they
have similar toxic effects on neuronal cells. First, we incubated
rat midbrain primary neuronal cultures with 40 nM of purified
oligomers and compared the ROS activity, measured using di-
hydroethidium (HEt) as a probe to quantify the production of
superoxide radicals, with the same mass concentration of the
monomeric and fibrillar forms of the protein. We have shown
previously thatmonomeric, oligomeric and fibrillar αS species are
all taken up very rapidly by both neurons and astrocytes (within 5-
10 minutes), without significant variations between the different
species (23), allowing us to correlate directly the effects of the
addition of the same amount of the different protein species to
the cells.
The results of these experiments show that addition of
monomeric αS produced a negligible change in ROS production
(with maximal values of HEt at 105.1 ± 6.7% of the basal rate;
n=72 cells; Figure 5C) while αS fibrils were found to elicit a
modest increase in ROS response in neuronal cells (218 ± 9%;
n=88, p<0.001). Addition of solutions of purified oligomers at
the same mass concentration (40 nM), however, produced a very
substantial increase in the rate of cellular ROS formation (327
± 16%; n=94 cells, p<0.0001) (Figure 5C), significantly higher
than that found for the fibrillar sample. To ensure that the effect
on neuronal cells upon exposure to the different αS species was
specific, we conducted a dose response assay. Figure 5D demon-
strates that exposing the neuronal cells to increasing concentra-
tions of both oligomeric and fibrillar αS resulted in step-wise
increases in cellular ROS production while the monomeric form
had no significant effect at any concentration tested. According
to our dose-response analysis in the nM protein concentration
range, the cells would require four times more protein in the
fibrillar state compared to the oligomeric state to be able to
produce a similar ROS response. This finding suggests that a
transition from αS oligomers to fibrils results in a substantial
reduction of ROS-induced cellular damage.
In order to probe further the toxicity of the oligomers, we
used calcein release assays to explore the ability of our oligomeric
species to cause membrane disruption in LUVs (Large Unilamel-
lar Vesicles) of lipid compositions similar to those that have been
used previously to examine the effects of αS oligomers (21, 24,
40). It has been shown that monomeric αS interacts with acidic
phospholipids, probably through the lysine residues located in
the N-terminal region of the protein (41), and a similar initial
interaction has been also proposed for some oligomeric confor-
mations (40). For this reason, most of the studies of membrane
disruption involving αS oligomeric species have been carried out
with a high content of acidic phospoholipids, typically 100 %
phosphatidylglycerol (PG) or phosphatidylserine (PS) (20, 40). It
has, however, been found that the effects of αS oligomers on the
dynamic properties of synthetic lipidic vesicles depend strongly on
the relative proportion of acidic and neutral phospholipids (21,
24). We therefore prepared LUVs containing only either POPS
(an acidic phospoholipid) or POPC (a neutral phospoholipid),
and also containing 1:1 and 3:7 POPS-POPC mixtures, with the
latter composition being the most physiologically relevant (42).
Because of its presence in brain membranes, we chose PS instead
of PG to increase the negative charge content of the vesicles.
As monomeric αS has been found to have its highest helical
content and ability to partition into a membrane at protein:lipid
(P:L) ratios of around 1:100 (43, 44), we compared the extent
of calcein release induced by the different αS species at this P:L
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ratio. In additional experiments, we used a P:L ratio of 1:10 in
order to compare the effect of αS species with the membrane
disrupting peptide mellitin (the major toxin of honey bee venom),
known to induce membrane permeabilization above this thresh-
old ratio (45). A summary of the results is given in Figure 5E,
and shows that oligomeric αS causes a higher calcein release from
the LUVs at both P:L ratios and at the various lipid composition
tested than either the monomeric or fibrillar forms of the protein.
LUVs composed only of POPS showed the highest level of calcein
release (over 60 %) in the presence of oligomers at P:L ratios of
1:10 and 1:100. Interestingly, at the low P:L ratio, αS oligomers
induce a much higher calcein release in those vesicles than the
toxic mellitin at any lipid composition tested except for pure
POPCLUVs. As the PS content in vesicles is reduced, less calcein
release is observed, with less than 20 % leakage at a P:L ratio of
1:100 and less than 50 % at a P:L ratio of 1:10 for the more phys-
iologically relevant 3:7 POPS-POPC LUVs. In addition, leakage
was not detected with only POPC vesicles. These data are in good
agreement with previously reported propensities of various types
of αS oligomers to induce disruption of highly negatively charged
membranes through formation of defects due to the intrinsic
instability of these types of vesicles to protein adsorption (21).
The trend observed for mellitin is the opposite of that for αS
oligomers, with the greatest perturbation effects with LUVs of
low acidic composition, an effect that also reflects the fact that
the interaction of the peptide with the bilayer surface is highly
dependent on the surface charge. Even though the presence of
negatively charged lipids is likely to promote melittin binding,
its propensity to induce leakage is more fundamentally governed
by its ability to penetrate into the hydrophobic region of the
membrane, which becomes more favourable the less electrostatic
interactions attract the peptide to the lipidic surface (46). The
behaviour of mellitin with respect to the P:L ratio that we have
obtained is also in agreement with the previously reported thresh-
old P:L ratio value for the effective mellitin-induced membrane
perturbation (45, 46). Taken together, the calcein release data
suggest that the αS oligomers described in the present study are
able to disrupt lipid vesicles with a high content of negatively
charge headgroups, which present an intrinsic instability of the
lipid bilayer. This finding is in agreement with previously reported
effects of αS oligomers on synthetic vesicles with similar lipid
composition (21, 24, 40). This effect is greater for the oligomers
than for either the monomeric or the fibrillar species showing
the greater ability of the former to affect membrane permeability
upon binding. Our data also suggest that the disruption mecha-
nism of disruption is unlikely to be similar to that of the pore-
forming melittin.
Discussion
Detailed information on the formation, structure, and mecha-
nisms of toxicity of oligomeric forms of amyloid aggregates is
of fundamental importance for developing our understanding
of the molecular origins and means of progression of protein
misfolding disorders, and as a basis for developing rational means
of therapeutic intervention. For this reason we have generated
and purified samples of stable αS oligomers at micromolar con-
centrations, and used a wide range of biophysical methods to
characterize the nature and distributions of their sizes, morpholo-
gies and structural characteristics. All the information accumu-
lated from these studies indicates that the purified αS oligomers
characterized here have a remarkably high degree of similarity,
in terms of physico-chemical, structural and toxic properties, with
oligomeric species formed by αS under different conditions and
other amyloidogenic peptides and proteins (16, 17, 21, 22, 24-
28, 47) and are representative of the most highly compact and
stable oligomeric αS species identified to accumulate during fibril
formation by means of single-molecule fluorescence techniques
(23).
Structural characteristics of oligomeric aggregates
The oligomers investigated in this work have structural fea-
tures that are intermediate between the intrinsically disordered
monomeric protein and the structurally highly organized mature
fibrils, reflected in terms of their size, compactness, β-sheet
content and resistance to proteolytic degradation. The 3D EM
reconstructions of the oligomers studied here reveal a broadly
cylindrical architecture that appears to be stable over a range
of oligomer sizes from ca. 160 to 560 kDa, as estimated by
AU-HYDROMIC analysis, with variable β-sheet content. The
size range determined for the oligomers present in our experi-
ments agrees well with the sizes of a variety of subgroups of αS
oligomers identified previously in samples generated using similar
approaches to that used in the present study (22, 28), although
some species have been reported to differ in their apparent mor-
phologies (22) and stabilities against urea denaturation (26). Two
major size subgroups, designated 10S and 15S, with molecular
weights of ca. 260 and 420 kDa on average (corresponding to
an average of ca. 18 and 29 protein molecules, respectively; note
that the overall size distribution of these two subgroups comprises
oligomers composed of 10 to 40 protein molecules), dominate the
distribution of oligomers in our sample, which have an average β-
sheet content of ca. 30 % and 40 % respectively, with the rest of
the protein being largely disordered, and a significant degree of
hydrophobic surface area exposed to the solvent.
In addition, we have found a strong correlation between
both the secondary structure content and the degree of exposed
hydrophobicity and the size of the oligomers, with the larger
oligomers showing a higher level of β-sheet content and a greater
area of hydrobobic surface exposed to the solvent. A similar
correlation between size and exposed hydrophobicity has been
recently observed for a model amyloidogenic protein generated
by mutagenesis (48), suggesting that such a relationship may
be a common feature of such species. Interestingly, the surface
hydrophobicity of the fibrillar form of αS is estimated to be
intermediate between the small and large oligomer subgroups,
despite their differences in size, a finding that reflects the differ-
ences in the β-sheet geometry between these oligomeric species
(predominantly anti-parallel β-sheet) and the fibrillar form of
the protein (mainly parallel β-sheet) already observed by FT-IR
spectroscopy.
The cryoEM and TEM image analyses of the αS oligomeric
species characterized here reveal essentially two major groups
of structural orientations that are independent of the sizes of
the oligomers, one with a ‘doughnut’ shape and the other one
with a cylindrical appearance, consistent with some previous
observations of αS oligomers (33). The high homogeneity of our
purified oligomeric sample together with the detail combined
EM-AU analysis have allowed us to carry out 3D reconstructions
on the two major size subgroups of oligomers present in our
samples. The average 3D reconstructions of the subgroups (10S
and 15S) reveal the same type of cylindrical architecture, with
dimensions that vary between ca. 120-140 Å in length and 90-100
Å in diameter in average, but with very similar dimensions for the
central cavity (ca. 25 Å in diameter). The average thickness of the
walls of the cylindrical structures (30 and 40 Å on average for the
10S and the 15S oligomer subgroups, respectively) is too large for
a folding core composed of a single β-sheet folded into a barrel
structure of the type recently found for a crystalline hexameric
species formed by a short segment of αB crystallin (12). The
dimensions of the oligomeric species described here are, instead,
much closer to those reported for fibrillar structures of αS from
cryo-negative EM studies, which are 80-120 Å in diameter, with
a central cavity of ca. 20-30 Å in diameter running through the
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structure (49), and indeed long cylindrical structures with water-
filled interfaces have been proposed for a wide variety of amyloid
fibrils (4, 5, 7-10) and similar protein regions as those found in the
fibrillar core have been suggested to be involved in intermolecular
contacts within αS oligomers prepared using a similar approach
to that we have used here (27).
This comparison suggests that it is possible that the self-
assembly of proteins into amyloid aggregates with β-sheet cores
generates similar structural architectures at both the fibrillar and
oligomeric level, regardless of the β-sheet geometry. Indeed, the
10S oligomeric structures described here are consistent with a
folding core composed of a pair of face-to-face β-sheets that are
further assembled into its cylindrical structure. Moreover, the
large 15S structure appear to be similar but with a higher β-sheet
content, probably as a result of the addition of further protein
molecules with similar structure (note that the average thickness
of the 10S and 15S cylindrical structures of these oligomers is
consistent with two and three β-strands per protein molecule,
respectively, separated by ca. 10Å, in agreement with the reported
intramolecular β-strand distance common to all amyloid fibrillar
structures (3)).
Similar 2D EM images of oligomers as those described here
have been previously reported for a range of amyloid peptides
and proteins collectively described as ‘amyloid pores’ (33). Most
of these amyloid oligomers have been found to bind the amy-
loid oligomer-specific A11 antibody (47), and, like them, the αS
oligomers described here are also able to bind to A11 (Figure S9),
suggesting that the underlying architecture we report here can
be adopted by different peptides and proteins, regardless of their
aminoacid composition and sequence, as previously proposed for
the the fibrillar structure (1, 2). The presence of a central cavity
in some oligomeric species has led to proposals that this specific
“pore-like” structure could be characteristic of some oligomers
and a key determinant of their toxicity (47). Based on our findings,
we propose that the cavity observed in amyloid oligomers is
likely to be an inherent property of the face-to-face packing of
pairs of β-sheets stabilized by inter-main chain hydrogen bonding
networks, as found for the amyloid fibrils, rather than a unique
structural feature of the amyloid oligomers.
Relationship between oligomeric and fibrillar aggregates
A close similarity between the global architecture of these
oligomers and that found to be characteristic of at least some
fibrils suggests that similar types of interactions (notably an array
of inter-backbone hydrogen bonds linking the β-strands as in
the fibrillar structures (6)) could stabilize both types of species.
If this is the case, a high degree of heterogeneity of β-sheet
oligomers with the same type of core architecture but different
numbers and lengths of β-strands, types of β-sheet arrengements,
and permutations of interstrand hydrogen bonding interactions
could be expected as has been observed to occur in fibrillar
structures, particularly of short peptides (4, 50). Indeed, it is
likely that the protein subunits within the same oligomeric species
will have different numbers and lengths of β-strands, reflecting
imperfections in the packing of the oligomers, as we have already
noticed during the EM analysis of the αS oligomeric samples
studied here. The accumulation of β-sheet rich oligomers with a
significant degree of heterogeneity in their β-sheet content could
well be a consequence of the extremely slow rates of assembly and
reorganization of amyloid-like β-sheet structures that we have
previously observed to be orders of magnitude slower than the
folding of small proteins into their native functional states (23).
An important difference between the oligomeric forms of
αS described here and the fibrils, despite their similarities in
overall architecture, is their relative ability to elongate. While
the fibrillar structures are readily able to increase in length, the
oligomeric species studied here have a much lower tendency
to grow by further addition of monomers (at least 3 orders of
magnitude slower than fibrils of similar size at the conditions
tested; Figure S10), a feature that has been reported previously
for samples ofαS oligomers prepared in a similarmaner (22). This
finding can be attributed to the differences in the arrangement of
the β-strands in the oligomers and the fibrils. Fibrils containing
anti-parallel β-sheets have been described, although mainly for
relatively short peptides (50, 51), and when compared with their
parallel counterparts they have been found at least in some
cases to be less stable and less efficient in elongating (50). Our
findings suggest that a rearrangement of the β-strands from an
anti-parallel to a parallel configuration would be required for
the efficient elongation of these αS oligomers to generate the
fibrillar architecture. Such a process is likely to be extremely
slow, perhaps involving the partial unfolding and disaggregation
of these oligomers by Ostwald ripening as recently observed for
the formation of other supramolecular assemblies (52), a fact
that could explain the high kinetic stability of these oligomeric
species. Moreover, it seems likely that oligomers with a parallel
β-sheet architecture, which our results suggest posseses lower
degree of surface-exposed hydrophobicity, and therefore a lower
level of intrinsic toxicity, are also formed in the early stages of αS
aggregation but are able to elongate rapidly and generate fibrils.
This conclusion highlights the role β-sheet geometry plays in the
process of misfolding and self-association of amyloid proteins, as
well as the importance of the rates (and energy barriers) of the
structural conversions between different β-sheet geometries for
dictating the kinetic stability of the different aggregated forms.
The toxicity of the oligomeric species
One of the most commonly reported measurements of the
toxicity of amyloid oligomers is the extent to which they dis-
rupt lipid membranes; the ability to generate such disruption
appear to be a general feature of all amyloid oligomers (16).
In agreement with previously reported data on the ability of
specific αS oligomers to disrupt synthetic lipid vesicles (21, 24,
40), we have observed that the oligomers characterized in the
present study are much more efficient in permeabilizing lipid
vesicles than are monomeric or fibrillar forms of αS at the same
mass concentration. Indeed, the oligomers are more efficient
than mellitin, a toxin peptide that acts through pore formation
(45), when the vesicles are primarily composed of negatively
charged phopholipids; when the content of acidic phospholipids
in the vesicles is reduced, we observed a gradual decrease of this
effect. Our data is fully consistent with the results of a previous
systematic analysis of the influence of the stability of synthetic
lipid vesicles on the degree to which they are perturbed by αS
oligomers (21), and suggest that the accessibility of the hydropho-
bic core of the bilayer is dependent on intrinsic defects in its
structure, such as those caused by a high content of negatively
charged phospholipids, and that such defects seem to be crucial
for the ability of αS oligomers to disrupt the lipid bilayer.
We also report here that the purified αS oligomers have
the ability to induce an aberrant production of ROS in primary
neuronal cells even at protein concentrations in the nM range.
Excessive generation of free radicals has itself been reported to
trigger pathological production of misfolded proteins, abnormal
mitochondrial function, and the stimulation of apoptotic path-
ways in neuronal cells (53). We find that αS fibrils would require
much higher protein concentrations to produce similar levels of
ROS than the oligomeric species studied here, while monomeric
protein molecules do not appear to stimulate detectable levels
of ROS production in neuronal cells. The differences in ROS
production between the oligomers and fibrils, normalised for the
number of protein molecules in each species, are likely to be a
result of the greater surface-to-volume ratio in the former species
or of differences in subcellular localization.
The fact that certain oligomeric species formed during amy-
loid aggregation can induce cellular ROS production has been
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reported previously for several systems (23, 54, 55), and is par-
ticularly relevant in the context of PD, as in this disorder the
link between oxidative stress and the development of disease is
well established (56). Furthermore, in the context of αS, it has
been reported that over-expression of αS increases the vulnera-
bility of neurons to dopamine-induced cell death through excess
intracellular ROS generation (57). Interestingly, increased ROS
and raised oxidative stress levels have been reported to cause
damage to neuronal membranes (58) and indeed to promote
further aggregation of αS (59), reflecting the fact that positive
feedback can occur between the different types of pathological
processes in PD.
Multiplicity of misfolding pathways and its significance for
disease
The high kinetic stability of the oligomers studied here can
be attributable to the anti-parallel nature of at least some of
the β-sheets within their core structures; as the fibrillar form of
aggregated αS is characterised by a parallel arrangement of β-
strands within the core structure, the rate of rearrangement of
this type of oligomer into species capable of efficient elongation
is likely to be extremely slow. By contrast, those oligomers within
the heterogeneous mixture of species formed early in the self-
assembly process that have assembled into structures containing
parallel □β-sheet, probably through reorganization of initially
more amorphous aggregates (23), are likely to be able to elongate
efficiently to form fibrils without the need for a major structural
reorganization, and hence to be transient in nature. An interest-
ing feature of this mechanism of multiple misfolding pathways is
that it is directly analogous to themultiplicity of parallel pathways
observed in the productive folding of a range of proteins and
shown to result from an initial collapse to disordered structures
followed by subsequent reorganizational events (60, 61). As pro-
posed here for misfolding and aggregation processes, in such
cases some pathways lead to rapid acquisition of stable structure
and others to the accumulation of metastable intermediates prior
to the slower accumulation of the more stable state.
The concept of a multiplicity of assembly steps resulting in
an ensemble of oligomers with differing β-sheet arrangements,
rates of elongation and inherent toxicities leads to the interesting
possibility that protein misfolding and aggregation process in
the cell can generate species with different pathological roles;
the elongation prone, fibril-like oligomers with parallel β-sheet
arrangement could act as key pathogenic species for the spreading
and transmission of the disease, whilst oligomers with an anti-
parallel β-sheet arrangement, such as that described here, could
accumulate within cells and, being highly hydrophobic and slow
to degrade because of their inherent resistance to proteolysis, act
as potent toxins.
Experimental Procedures
Preparation of puriﬁed αS oligomeric samples
αS oligomeric samples were prepared on the basis of previous protocols
(17, 21, 22, 24, 25, 27, 40, 62, 63). Brieﬂy, six mg of lyophilized protein was
resuspended in PBS buffer, pH 7.4, to give a ﬁnal concentration of ca. 800
μM (12 mg/ml), and passed through a 0.22 μm cut off ﬁlter immediately
prior to incubation at 37 °C for 20-24 h without agitation or the application
of any other process that could induce shear and hence accelerate the
conversion of monomers and oligomers into ﬁbrils (23, 29). During this time,
a very small number of ﬁbrillar species were observed to form and removed
by ultracentrifugation for 1 h at 90,000 rpm (using a TLA-120.2 Beckman
rotor; 288,000 x g). The excess of monomeric protein, as well as the low
levels of very small oligomers, were removed by means of multiple ﬁltration
steps (using 100 kDa cut-off membranes) in order to enrich the sample in
pure oligomeric species of αS (see Supplemental Experimental Procedures
for a full description of the protocol). The oligomeric samples were found
to remain stable for days (Figure S1) and were used within the ﬁrst two
days after their production. The concentrations of the ﬁnal solutions of
oligomers were estimated from the absorbance at 275 nm using a molar
extinction coefﬁcient of 5600 M-1.cm-1 (no signiﬁcant changes in the molar
extinction coefﬁcient value were found for the oligomeric species relative to
the monomeric protein). The concentration values given in the manuscript
represent the total mass concentration of protein, i.e. the total concentration
in monomer equivalents.
We noted that there was a substantial enrichment in stable αS oligomers
when lyophilized protein stock solutions were used as compared with non-
lyophilized protein samples and these oligomeric species have been shown to
have a high degree of similarity to oligomeric species formed when freshly
prepared protein is incubated under standard conditions that lead to the
formation of amyloid ﬁbrils (see (17, 21, 22, 24, 27, 40, 63) and the results
from the present study). These oligomeric species are thermodynamically and
kinetically very stable (see Figure 3 and Figure S1), a property attributable
to their amyloid-like structural architecture and their anti-parallel β-sheet
arrangement, and can be isolated and remain stable for days after they are
produced, even in the presence of monomeric protein (see Figure S1).
Sedimentation velocity experiments by analytical ultracentrifugation
Sedimentation velocity measurements were performed at 20oC,
38,000–43,000 rpm (106,750–136,680 g) using a Beckman-Coulter Optima
XL-I analytical ultracentrifuge equipped with UV-visible absorbance optics
and an An50Ti rotor. All protein samples (40-80 μM) were incubated in their
respective buffers for at least 6 hours prior to the start of the sedimentation
velocity experiments. The sedimentation coefﬁcient distributions, corrected
to standard conditions using the SEDNTERP program (64), were calculated
via least-squares boundary modelling of sedimentation velocity data us-
ing the c(s) and ls-g*(s) methods, as implemented in the SEDFIT program
(http://www.analyticalultracentrifugation.com/default.htm).
Cryoelectron microscopy and image processing
Protein aliquots were applied to glow-discharged, holey carbon grids
(carbon-coated Quantifoil R 1.2/ R1.3 300 mesh grids) containing an ad-
ditional continuous thin layer of carbon and plunged into liquid ethane.
Images were acquired under minimal dose conditions with a Tecnai F20
transmission electron microscope at 200 kV. The images were taken at a
magniﬁcation of 50 000 x using a 16 megapixel (Mpx) FEI Eagle CCD
camera with a step size of 15 μm; thus the original pixel size of the
acquired images was 2.74 Å. Individual particles were selected manually
and extracted using XMIPP software (65). Particle classiﬁcation was carried
out using maximum-likelihood multi-reference reﬁnement approaches and
the resulting class averages and their corresponding assigned particles were
visually separated into twomain size groups (as suggested by the AU analysis
of the samples) on the basis of their overall dimensions, and then subjected
to an iterative procedure consisting of several rounds of 2D classiﬁcation
in order to enable a clearer separation of the two size populations (Figure
S6). For the 3D reconstruction of the two populations that were resolved,
several starting reference models and initial 3D reconstruction steps based
on iterative angular reﬁnement were performed using the EMAN software
package (66) (see Suppplemental Information formore details). The different
strategies converged to similar solutions, and one of the models for each
population was selected to complete the reﬁnement. The resolution of the
3D reconstructions determined by the FSC 0.5 criterion was 18 Å and 19
Å for the small and large oligomer population, that would correspond to
the10S and 15S oligomer subgroups identiﬁed by AU, repectively.. A detailed
description of the EM methodology as well as the rest of the experimental
procedures can be found in Supplemental Experimental Procedures.
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